| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −8.3× | −1.7× | |
| Price / Book | 6.5× | 2.0× | |
| Price / Sales | — | 4.0× | — |
| Price / Free cash flow | −12.6× | −1.5× | |
| EV / EBITDA | −8.2× | −1.2× | |
| Earnings yield | −12.0% | −14.4% | |
| Free cash flow yield | −7.9% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,279.63 | +3.17% | $1.2T | 56.6× | 77.8% | +15.2% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $258.06 | +1.68% | $621.9B | 22.8× | 32.9% | +32.1% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $287.00 | +1.53% | $507.16B | 118.2× | −129.2% | +24.6% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $412.47 | +1.37% | $370.23B | 30.3× | 12.8% | +14.1% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $147.47 | +2.67% | $363.83B | 19.4× | 34.7% | +71.2% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $152.37 | +1.44% | $280.89B | 19.7× | 30.5% | +14.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $167.36 | +2.08% | $259.56B | 24.8× | 21.1% | −2.4% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $684.53 | +0.76% | $253.1B | 37.3× | 12.6% | +26.6% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $429.73 | +1.13% | $232.33B | 29.8× | 89.1% | +43.7% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $156.00 | +1.91% | $193.43B | 22.3× | 37.5% | +29.9% |
